The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer
Gastric cancer[1], also known as Stomach cancer is the third most serious gastrointestinal neoplasm worldwide, with a survival rate of about 30 –35% in the last two decades[2,3]. GC is a molecularly and histologically diverse disease that according to the locus of the tumor is categorized into two types: gastroesophageal junction adenocarcinoma (G/GEA) and gastric adenocarcinomas[4,5]. Stomach cancer is typically an asymptomatic disease o r may present with vague and imprecise symptoms in the early stages.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Atousa Ghorbani, Fatemeh Hosseinie, Saeideh Khorshid Sokhangouy, Muhammad Islampanah, Fatemeh khojasteh-Leylakoohi, Mina Maftooh, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A Ferns, Majid Khazaei, Elham Nazari, Amir Avan Tags: Review Article Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Genetics